Contents of Kit
1. Break apart microtiter test strips each with 8 antigen coated single wells (altogether 96), 1 frame, the coating material is inactivated. 12
2. Standard serum (ready-to-use), Human serum in phosphate buffer with protein; negative for anti-HIV-Ab, HBs-Ag (Hepatitis B-Virus -surface antigen) and anti-HCV-Ab; preservative: < 0.1% sodium azide, colouring: Amaranth O. 2 × 2 ml
3. Negative control serum (ready-to-use), Human serum in phosphate buffer with protein; negative for anti-HIV-Ab, HBs-Ag (Hepatitis B-Virus -surface antigen) and anti-HCV-Ab; preservative: < 0.1% sodium azide, colouring: Lissamine green V. 2 ml
4. Anti-human-IgG-conjugate (ready-to-use), Anti-human-IgG from goat (polyclonal), conjugated to alkaline phosphatase, stabilized with protein stabilization solution preservative: 0.01 % methylisothiazolone, 0.01 % bromnitrodioxane.13 ml
5. Washing solution concentrate (sufficient for 1 litre), Sodium chloride solution with Tween 20, 30 mM Tris preservative: < 0.1% sodium azide, 33.3 ml
6. Dilution buffer or specific IgM dilution buffer Parvovirus B19, Phosphate buffer with protein and Tween 20; preservative: < 0.1% sodium azide, 0.01 g/l Bromphenol blue sodium salt, E. coli-lysate / specific IgM dilution buffer. 2 × 50 ml
7. Stopping solution, 1.2 N sodium hydroxide. 15 ml
8. Substrate (ready-to-use), Para-nitrophenylphosphate, solvent free buffer, preservative: < 0.1 % sodium azide, (Substrate in unopened bottle may have a slightly yellow color. This does not reduce the quality of the product!) 13 ml.
General Description
Parvovirus B19 is the most important pathogen for clinically relevant human infections with Parvoviruses. The virus replicates in dividing human erythroid cells.
Parvovirus B19 is ubiquitous. In industrialized countries 2-10% of children younger than 5 years had an infection and 40-60 % of individuals older than 20 years show Parvovirus B19 antibodies. Parvovirus B19 infections are mainly transmitted by naso-pharyngal secretion (droplet infection), due to close contact with infected individuals. In 5% of pregnant women the infection is transmitted to the fetus, leading to different types of fetopathy. In the first and second trimesters the risk of fetal abortion is highest. Transmission of Parvovirus B19 infections by blood or plasma donation in the phase of viremia was rarely reported. ELISA test-systems are especially suited for the detection of Parvovirus B19 IgM and IgG due to their accurate immunoglobulin class specific analysis of the immune response.